Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein
Jinsoo Kim1,†, Seok Young Hwang2,†, Dongbum Kim3,†, Minyoung Kim1, Kyeongbin Baek1, Mijeong Kang1, Seungchan An2, Junpyo Gong2, Sangkyu Park4, Mahmoud Kandeel5,6, Younghee Lee4, Minsoo Noh2,* and Hyung-Joo Kwon1,3,*
1Department of Microbiology, College of Medicine, Hallym University, Chuncheon 24252,
2College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826,
3Institute of Medical Science, College of Medicine, Hallym University, Chuncheon 24252,
4Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju 28644, Republic of Korea
5Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-hofuf 31982, Saudi Arabia
6Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelshikh University, Kafrelshikh 33516, Egypt
*E-mail:
hjookwon@hallym.ac.kr (Kwon HJ),
minsoonoh@snu.ac.kr (Noh M)
Tel: +82-33-248-2635 (Kwon HJ), +82-02-880-2481 (Noh M)
Fax: +82-33-241-3640 (Kwon HJ), +82-02-880-2482 (Noh M)
†The first three authors contributed equally to this work.